A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction

Clinical trial NCT02202759 · TERMINATED

Trial details

NCT number: NCT02202759
Sponsor: Millennium Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Stomach Gastroesophageal Junction Expressing Guanylyl Cyclase C

Start date: 2014-08-04
Primary completion: 2016-01-15
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.